I think you summarized it well, Joanne.
There are a number of factors that come into consideration in some of the earlier points that were raised: a manufacturer's credibility and their ability to supply and comply with challenges with supply chains. Vaccines are extremely difficult to make, even the routine vaccines. With one that was so new, it was inevitable there would be some supply chain issues along the way. We took all of that into consideration in formulating our advice and providing it to the ministers.